GRML
Greenland Mines Ltd. Common Stock (GRML)
Basic Materials • NASDAQ • $0.46-7.41%
- Symbol
- GRML
- Exchange
- NASDAQ
- Sector
- Basic Materials
- Industry
- Other Precious Metals & Mining
- Price
- $0.46
- Daily Change
- -7.41%
- Market Cap
- $55.78M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $3.91
- 52W Low
- $0.12
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 2.62
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Company websiteResearch GRML on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.